FierceBiotech Mar 19, 2026 Lilly's obesity discovery partner Fauna sees weight loss potential in hibernating mammals
FierceBiotech Mar 19, 2026 AstraZeneca to build cell therapy manufacturing hub, R&D center in Shanghai
FierceBiotech Mar 19, 2026 Phage-focused BiomX resets after adverse events derail pipeline, considers pivot to defense sector
FierceBiotech Mar 19, 2026 Syneos Health scoops up Chinese CRO to secure place in ‘rapidly growing market’
FierceBiotech Mar 19, 2026 Lilly's triple-G bet lowers blood sugar, prompts 16.8% weight loss in phase 3 diabetes trial
FierceBiotech Mar 19, 2026 Rare disease advocates stage 'funeral' at FDA, demand 4 actions of agency and Congress
FierceBiotech Mar 18, 2026 Beyond seizures: With experimental drug, Stoke aims to restore developmental loss in Dravet syndrome
FierceBiotech Mar 18, 2026 JenaValve's Trilogy valve secures FDA's 1st approval in aortic regurgitation
FierceBiotech Mar 17, 2026 Xaira exec divulges R&D focus, how $1B fundraise fuels AI-driven hunt for what the 'industry is hungriest for'
FierceBiotech Mar 17, 2026 FDA rejects Aldeyra dry eye disease drug for 3rd time, citing inconsistent study findings
FierceBiotech Mar 17, 2026 Hitting regulatory roadblock, Bicycle pumps brakes on lead program and deflates headcount by 30%